Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The efficacy of therapeutic plasma exchange in COVID-19 patients on endothelial tightness in vitro is hindered by platelet activation.
Ebermeyer T, Hequet O, Berard F, Prier A, Eyraud MA, Arthaud CA, Heestermans M, Duchez AC, Guironnet-Paquet A, Berthelot P, Cognasse F, Hamzeh-Cognasse H. Ebermeyer T, et al. Among authors: hequet o. Front Cardiovasc Med. 2023 May 4;10:1094786. doi: 10.3389/fcvm.2023.1094786. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37215546 Free PMC article.
Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology.
Cognasse F, Hamzeh-Cognasse H, Duchez AC, Shurko N, Eyraud MA, Arthaud CA, Prier A, Heestermans M, Hequet O, Bonneaudeau B, Rochette-Eribon S, Teyssier F, Barlet-Excoffier V, Chavarin P, Legrand D, Richard P, Morel P, Mooney N, Tiberghien P. Cognasse F, et al. Among authors: hequet o. Front Immunol. 2022 Oct 7;13:1034379. doi: 10.3389/fimmu.2022.1034379. eCollection 2022. Front Immunol. 2022. PMID: 36275757 Free PMC article.
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study.
Cognasse F, Hamzeh-Cognasse H, Rosa M, Corseaux D, Bonneaudeau B, Pierre C, Huet J, Arthaud CA, Eyraud MA, Prier A, Duchez AC, Ebermeyer T, Heestermans M, Audoux-Caire E, Philippot Q, Le Voyer T, Hequet O, Fillet AM, Chavarin P, Legrand D, Richard P, Pirenne F, Gallian P, Casanova JL, Susen S, Morel P, Lacombe K, Bastard P, Tiberghien P. Cognasse F, et al. Among authors: hequet o. EBioMedicine. 2023 Jan;87:104414. doi: 10.1016/j.ebiom.2022.104414. Epub 2022 Dec 17. EBioMedicine. 2023. PMID: 36535107 Free PMC article.
Adverse Events and Infectious Complications in the Critically Ill Treated by Plasma Exchange: A Five-Year Multicenter Cohort Study.
François M, Daubin D, Menouche D, Gaillet A, Provoost J, Trusson R, Arrestier R, Hequet O, Richard JC, Moranne O, Larcher R, Klouche K. François M, et al. Among authors: hequet o. Crit Care Explor. 2023 Oct 27;5(11):e0988. doi: 10.1097/CCE.0000000000000988. eCollection 2023 Nov. Crit Care Explor. 2023. PMID: 38304709 Free PMC article.
Second line extracorporeal photopheresis for cortico-resistant acute and chronic GVHD after allogeneic hematopoietic cell transplantation for hematological malignancies: Long-term results from a real-life study.
Michallet M, Sobh M, Deloire A, Revesz D, Chelgoum Y, El-Hamri M, Barraco F, Labussiere H, Nicolini FE, Hequet O. Michallet M, et al. Among authors: hequet o. Transfus Apher Sci. 2024 Jun;63(3):103899. doi: 10.1016/j.transci.2024.103899. Epub 2024 Feb 16. Transfus Apher Sci. 2024. PMID: 38402067
Rituximab and plasmapheresis for severe post-transplant auto-immune hepatitis.
Dumortier J, Chouik Y, Hequet O, Hervieu V, Boillot O. Dumortier J, et al. Among authors: hequet o. Clin Res Hepatol Gastroenterol. 2022 Mar;46(3):101844. doi: 10.1016/j.clinre.2021.101844. Epub 2021 Dec 15. Clin Res Hepatol Gastroenterol. 2022. PMID: 34920142 No abstract available.
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells.
Sesques P, Tordo J, Ferrant E, Safar V, Wallet F, Dhomps A, Brisou G, Bouafia F, Karlin L, Ghergus D, Golfier C, Lequeu H, Lazareth A, Vercasson M, Hospital-Gustem C, Schwiertz V, Choquet M, Sujobert P, Novelli S, Mialou V, Hequet O, Carras S, Fouillet L, Lebras L, Guillermin Y, Leyronnas C, Cavalieri D, Janier M, Ghesquières H, Salles G, Bachy E. Sesques P, et al. Among authors: hequet o. Clin Nucl Med. 2021 Aug 1;46(8):627-634. doi: 10.1097/RLU.0000000000003756. Clin Nucl Med. 2021. PMID: 34115706
Effects of Genotypes and Treatment on Oxygenscan Parameters in Sickle Cell Disease.
Boisson C, Rab MAE, Nader E, Renoux C, Kanne C, Bos J, van Oirschot BA, Joly P, Fort R, Gauthier A, Stauffer E, Poutrel S, Kebaili K, Cannas G, Garnier N, Renard C, Hequet O, Hot A, Bertrand Y, van Wijk R, Sheehan VA, van Beers EJ, Connes P. Boisson C, et al. Among authors: hequet o. Cells. 2021 Apr 5;10(4):811. doi: 10.3390/cells10040811. Cells. 2021. PMID: 33916502 Free PMC article.
[How to perform leukapheresis for procurement of the staring material used for commercial CAR T-cell manufacturing: A consensus from experts convened by the SFGM-TC].
Carnoy S, Beaumont JL, Kanouni T, Parquet N, Beauvais D, Hequet O, Kanold J, Ballot C, Mialou V, Reppel L, Damaj G, Yakoub-Agha I, Chabannon C. Carnoy S, et al. Among authors: hequet o. Bull Cancer. 2021 Mar;108(3):295-303. doi: 10.1016/j.bulcan.2020.11.014. Epub 2021 Feb 17. Bull Cancer. 2021. PMID: 33610284 Review. French.
60 results